Top Markets
Coin of the day
DiaSorin S.p.A. DiaSorin S.p.A.

DiaSorin S.p.A.

DIA
Clasificación en acciones #3923
DiaSorin S.p.A. engages in research and development, manufacture, and... DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Precio por acción
$89.96
Capitalización bursátil
$4.45B
Cambio (1 día)
-0.16%
Cambio (1 año)
-14.59%
País
IT
Comercio DiaSorin S.p.A. (DIA)

Categoría

EPS de DiaSorin S.p.A. (DIA)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de DiaSorin S.p.A., el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de DiaSorin S.p.A. desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras